Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

Commenting on the Centers for Medicare & Medicaid Services’ hospital inpatient prospective payment system final rule for fiscal year 2022, the AHA expresses concern that the rule prioritizes Health Professional Shortage Areas and training time in HPSAs when distributing new graduate medical education slots to teaching hospitals, methods that do not reflect statutory intent and are operationally complicated.
The AHA and seven other national hospital organizations turge congressional leaders to act quickly to ensure hospitals and health systems have the additional resources they need to continue to care for their communities and patients during the COVID-19 pandemic, including additional relief from Medicare sequester cuts in 2022.
AHA comments on a discussion draft of bipartisan legislation to strengthen the nation’s public health and medical preparedness and response systems in the wake of the COVID-19 pandemic.
Letter to CMS with AHA’s comments on proposed Notice of Benefit and Payment Parameters for 2023.
by Rick Pollack, President and CEO, AHA
AHA member hospitals and health systems are committed to supporting the health care workforce. We support lifting the cap on Medicare-funded physician residencies; boosting support for nursing schools and faculty; providing scholarships and loan forgiveness; and, expediting visas for all highly trained foreign health care workers.
AHA letter to Representatives Pressley, Titus, McKinley, and Meijer expressing support for the Post-Disaster Mental Health Response Act (H.R. 5703).
AHA Urges HRSA to delay effective withdrawal date for HPSAs designated as “proposed for withdrawal” by at least one year.
AHA letter to Representative Donald Norcross expressing support for bipartisan legislation, the Opioid Treatment Access Act (H.R. 6279).